Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Cariski AT"'
Autor:
Denise Cariski, Keith G. Davies, Bruce P. Hermann, Malachy Bishop, Paul Rutecki, Austin Woodard, Brian Bell, Michael Seidenberg, Jay Rosenbek
Publikováno v:
Epilepsy & Behavior. 3:158-164
Purpose. Decline in confrontation naming ability occurs in a subset of temporal lobe epilepsy (TLE) patients following left (dominant) anterior temporal lobectomy (ATL). Patients with late age of onset of seizures are most vulnerable to such decline.
Publikováno v:
Current Medical Research and Opinion. 18:479-487
To compare the efficacy and safety of cilostazol in diabetic and non-diabetic patients from eight (six placebo- and two active-controlled) randomised, double-blind phase III trials.We only included patients from the trial data set receiving cilostazo
Publikováno v:
American Journal of Health-System Pharmacy. 64:584-586
We read with interest the report by Rivers and colleagues[1][1] comparing the precision and accuracy of two blood glucose monitoring systems. In the interest of improving the value of future glucose meter evaluations, we would like to highlight four
Autor:
J. Kumpula, J. Rosenbek, J. G. Lyon, C. Ryff, D. Cariski, R. Levine, S. Coyne, L. Keisler, M. Blanc
Publikováno v:
Aphasiology. 11:693-708
Communication partners is a novel aphasia treatment plan whose aim is to restore a sense of purpose, direction, and control to daily life for both patient and caregiver. Treatment involves the participation of a community volunteer who, once paired w
Autor:
Alan T. Cariski
Publikováno v:
Drug Information Journal. 29:603-607
The Food and Drug Administration (FDA) requires patient package inserts (PPJs) only for a limited number of medicinal products and therapeutic devices, including at least four classes of drugs (oral contraceptives, estrogens, progestational agents, a
Autor:
Alan T. Cariski, Katalin Lindmayer
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 59(1)
Autor:
A T, Cariski
Publikováno v:
International journal of clinical practice. Supplement. (119)
Cilostazol is a phosphodiesterase III inhibitor with antiplatelet, antithrombotic and vasodilatory effects. It raises plasma high-density lipoprotein cholesterol levels by approximately 10% and lowers plasma triglycerides by approximately 15%. Eight
Publikováno v:
American Journal of Critical Care. 18:192-193
Publikováno v:
Diabetes Technology & Therapeutics. 9:200-201
Autor:
Gould, A L, Cariski, A T
The authors assessed the clinical results of lipid-lowering therapy in women.The Program on the Surgical Control of the Hyperlipidemias (POSCH) has demonstrated that effective lowering of total cholesterol and low-density lipoprotein cholesterol in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::565aa9ae5d519d2bcc056ea54a637280
https://europepmc.org/articles/PMC1191259/
https://europepmc.org/articles/PMC1191259/